HighTower Advisors »

Allogene Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $82k 26k 3.21
2023-09-30 $176k 56k 3.15
2023-06-30 $279k 56k 4.95
2023-03-31 $280k 57k 4.92
2022-12-31 $361k 57k 6.30
2022-09-30 $734k 68k 10.78
2022-06-30 $776k 68k 11.40
2022-03-31 $462k 51k 9.14
2021-12-31 $753k 51k 14.88
2021-09-30 $1.3M 52k 25.73
2021-06-30 $1.2M 46k 26.11
2021-03-31 $1.7M 48k 35.27
2020-12-31 $1.2M 48k 25.23
2020-09-30 $1.7M 45k 37.72
2020-06-30 $2.0M 46k 42.71
2020-03-31 $1.1M 56k 19.42
2019-09-30 $630k 23k 27.23
2019-06-30 $306k 11k 26.84